Toshiba America Medical Systems, Inc. announced the enrollment of 400 patients in its CorE 64 (Coronary Evaluation on 64) study taking place across seven countries, evaluating the use of 64-slice CT technology.
Toshiba’s CorE 64 trial investigates the use of multi-slice CT as a diagnostic tool for detecting cardiovascular diseases and disorders, as compared to cardiac catheterization. Data collected to date from CorE 64 indicates CT as a diagnostic alternative to cardiac catheterization and has the potential to change the delivery of healthcare.
“We expect CorE 64 findings to impact the overall reimbursement guidelines for multi-slice CT, resulting in greater patient access to these exams and to have significant economic benefits for 64-slice CT,” explained Toshihiro Rifu, senior fellow, Toshiba Medical Systems Corporation.
The CorE 64 multi-center study participants include nine sites across seven countries:
- Johns Hopkins University School of Medicine, in Baltimore, Md., led by primary investigators Drs. João A. C. Lima and Julie Miller;
- Johns Hopkins Bayview Medical Center in Baltimore, Md.;
- Beth Israel Deaconess Medical Center at Harvard in Boston, Mass.;
- Leiden University Medical Center in the Netherlands;
- Humboldt University, Campus Charité Mitte in Germany;
- INCOR Heart Institute of the School of Medicine Hospital, Sao Paulo University in Brazil;
- Iwate Medical University in Japan;
- Mount Elizabeth Hospital in Singapore; and
- Toronto General Hospital, University Health Network and Mount Sinai Hospital in Canada.
For more information about CorE 64, please visit www.medical.toshiba.com